ANI CEO Przybyl To Depart After 11 Years

Comes As Firm Gears Up For Cortrophin Gel Entry

 
• By Dean Rudge

ANI Pharmaceuticals has been steered by former Akorn head Arthur Przybyl since March 2009. But he will bring the curtain down on his time with the company next month, as the company recruits his replacement ahead of a key branded product launch.

Exit
ANI CEO Arthur Przybyl is heading for the exit door after more than a decade of service • Source: Shutterstock

More from Leadership

More from Generics Bulletin